28 September 2017 EMA/642432/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): carbomers

Procedure No.: PSUSA/00000557/201701

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

AquaTears®-Augengel CIVIGEL 0,2 %, gel ophtalmique DACRIO GEL® DACRIOGEL® 0,3% Gel oftalmico DACRIOGEL® 0,3% Gel oftalmico GEL LARMES, gel ophtalmique GEL LARMES, gel ophtalmique GEL LARMES, gel ophtalmique en récipient unidose GEL LARMES, gel ophtalmique en récipient unidose GEL LARMES, gel ophtalmique en récipient unidose GEL LARMES, gel ophtalmique en récipient unidose GelTears Geltears 0.2% w/w Carbomer Eye Gel LACRIFLUID 0,13 %, collyre en solution LACRIFLUID 0,13 POUR CENT, collyre en solution en récipient unidose LACRIGEL, gel ophtalmique Lacrigel® C 1 g Augengel enthält 2 mg Carbomer Lacrigel® C sine LACRINORM 0,2 POUR CENT, gel ophtalmique LACRINORM 0,2 POUR CENT, gel ophtalmique LACRINORM 2 mg/g gel ophtalmique LACRINORM 2 mg/g ooggel LACRYVISC 3 mg/g gel oftalmic Lacryvisc 3 mg/g gel oftálmico

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

not available not available not available

1-22533 NL 20 483 8579/6-2-2007

not available

032148037

ALCON ITALIA S.P.A.

IT

not available not available not available

032148049 331947-5 331948-1

ALCON ITALIA S.P.A. LABORATOIRES THEA LABORATOIRES THEA

IT FR FR

not available

334713-5

LABORATOIRES THEA

FR

not available

334714-1

LABORATOIRES THEA

FR

not available

356 506-2

LABORATOIRES THEA

FR

not available not available

389025-3 PL 03468/0043

LABORATOIRES THEA BAUSCH & LOMB UK LTD.

FR UK

not available

PA 555/011/001

BAUSCH & LOMB UK LTD.

IE

not available

3400935528698

LABORATOIRES EUROPHTA

FR

not available not available

29545-3400937688710 16166-3400933521134

LABORATOIRES EUROPHTA LABORATOIRES EUROPHTA

FR FR

not available not available

57627.00.00 50170.00.00

DR. WINZER PHARMA GMBH DR. WINZER PHARMA GMBH

DE DE

not available

34009 336 665 8 3

LABORATOIRE CHAUVIN

FR

not available

34009 336 666 4 4

LABORATOIRE CHAUVIN

FR

not available not available not available not available

BE 193365 BE 193365 5351/2005/01 3114584

BAUSCH & LOMB PHARMA BAUSCH & LOMB PHARMA LABORATORIES ALCON S.A. ALCON PORTUGAL - PRODUTOS E

BE BE RO PT

List of nationally authorised medicinal products EMA/642432/2017

LABORATOIRES THEA LABORATORIES ALCON S.A. ALCON LABORATORIES HELLAS S.A.

AT FR GR

Page 2/7

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

LACRYVISC 3 mg/g gel za oko LACRYVISC gel ophtalmique en récipient unidose LACRYVISC, gel ophtalmique Lakrimont 2 mg/g ögongel Lakrimont 2mg/g eye gel Lakrimont, øjengel

not available

H/97/00867/001

not available not available SE/H/1517/001 SE/H/1517/01 SE/H/1517/001

NL 17 932 NL 17 931 43207 12-9319 51795

Liposic

not available

30650.00.00

Liposic EDO

not available

40613.00.00

Liposic Fluid Liquigel 2,5 mg/g Augengel LIQUIGEL UD 2,5 mg/g Augengel im Einzeldosisbehältnis LlQUlVISC 2.5 mg/g, eye gel LlQUlVISC 2.5 mg/g, eye gel OCUGEL – 2,5 mg/g – gel ophtalmique OCUGEL - 2,5 mg/g - ooggel OCUGEL – 2,5 mg/g – ooggel OCUGEL Monodoses 2,5 mg/g Augengel OCUGEL Monodoses 2,5 mg/g Augengel OCUGEL Monodoses 2,5 mg/g gel ophtalmique OCUGEL Monodoses 2,5 mg/g gel ophtalmique OCUGEL Monodoses 2,5 mg/g Ooggel OCUGEL, 2,5 mg/g, Augengel OCUGEL, 2,5 mg/g, Augengel

not available not available

MAH of product in the member state

EQUIPAMENTOS OFTALMOLÓGICOS, LDA. SA ALCON-COUVREUR NV

Member State where product is authorised

SI FR FR SE NO DK

40610.00.00 ZUL.-NR. 37899.00.00

LABORATORIES ALCON S.A. LABORATORIES ALCON S.A. BLUMONT PHARMA LTD BLUMONT PHARMA LTD BLUMONT PHARMA LTD DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH LABORATOIRES THEA

not available FR/H/0118/001 FR/H/0118/001

ZUL.-NR. 37898.00.00 PA 1107/002/001 PL 20162/0009

LABORATOIRES THEA LABORATOIRES THEA LABORATOIRES THEA

DE IE UK

not available not available not available

BE199306 2005/038706 BE 199306

S.A. MEDA PHARMA N.V. S.A. MEDA PHARMA N.V. S.A. MEDA PHARMA N.V.

BE LU BE

not available

BE269866

S.A. MEDA PHARMA N.V.

BE

not available

2005/100019

S.A. MEDA PHARMA N.V.

LU

not available

BE269866

S.A. MEDA PHARMA N.V.

BE

not available

2005/100019

S.A. MEDA PHARMA N.V.

LU

not available not available not available

BE269866 BE199306 2005/038706

S.A. MEDA PHARMA N.V. S.A. MEDA PHARMA N.V. S.A. MEDA PHARMA N.V.

BE BE LU

List of nationally authorised medicinal products EMA/642432/2017

DE DE DE DE

Page 3/7

Product Name (in authorisation country)

Oftagel Oftagel 2,5 mg/g acu gels OFTAGEL 2,5 mg/g akių gelis Oftagel 2,5 mg/g augnhlaup OFTAGEL 2,5 mg/g oční gel OFTAGEL 2,5 mg/g očný gél Oftagel 2,5 mg/g ögongel Oftagel 2,5 mg/g ögongel OFTAGEL 2,5 mg/g ögongel i endosbehållare Oftagel 2,5 mg/g ögongel, endosbehållare Oftagel 2,5 mg/g øyegel Oftagel 2,5 mg/g øyegel i endosebeholder Oftagel 2,5 mg/g -silmägeeli Oftagel 2,5 mg/g -silmägeeli kerta-annospipetissä Oftagel 2,5 mg/g szemgél OFTAGEL 2,5 mg/g, augnhlaup í stakskammtaíláti Oftagel 2.5 mg/g silmageel Oftagel, 2,5 mg/g, zel do oczu SICCAFLUID 2,5 mg/g , gel oftálmico SICCAFLUID 2,5 mg/g gel oftalmico SICCAFLUID 2,5 mg/g gel oftálmico Siccafluid 2,5 mg/g gel oftalmico in contenitore monodose Siccafluid 2,5 mg/g gel oftalmico in contenitore monodose Siccafluid 2,5 mg/g gel oftalmico in contenitore

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

not available not available not available FR/H/118/01/E01 not available not available not available not available

19497 01-0137 LT/1/2000/1467/001 IS/1/03/015/01 64/296/02-C 64/0063/04-S 13023 14206

not available

20849

SANTEN OY

FI

not available FR/H/118/01/E01

22390 03-1678

SANTEN OY SANTEN OY

SE NO

MRP FR/H/118/02 not available

04-3155 13023

SANTEN OY SANTEN OY

NO FI

not available not available

20849 OGYI T-9682/01

SANTEN OY SANTEN OY

FI HU

MRP FR/H/118/02 not available not available

IS/1/05/042/01 311600 9808

SANTEN OY SANTEN OY SANTEN OY

IS EE PL

FR/H/0118/001

62114

LABORATORIOS THEA S.A.

ES

FR/H/0118/001

033816012

LABORATOIRES THEA

IT

FR/H/0118/001

2717585

LABORATOIRES THEA

PT

FR/H/0118/002

033816024

LABORATOIRES THEA

IT

FR/H/0118/002

033816036

LABORATOIRES THEA

IT

FR/H/0118/002

033816048

LABORATOIRES THEA

IT

List of nationally authorised medicinal products EMA/642432/2017

SANTEN OY SANTEN OY SANTEN OY SANTEN OY SANTEN OY SANTEN OY SANTEN OY SANTEN OY

DK LV LT IS CZ SK FI SE

Page 4/7

Product Name (in authorisation country)

monodose Siccafluid 2,5 mg/g gel oftalmico in contenitore monodose SICCAFLUID 2,5 mg/g, gel ophtalmique SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose SICCAFLUID 2,5 mg/g. gel oftálmico en unidosis Siccafluid Unidose, 2,5 mg/g ooggel in verpakking voor éénmalig gebruik SICCAFLUID, 2,5 mg/g, gel oftálmico em recipiente unidose SICCAFLUID, 2,5 mg/g, gel oftálmico em recipiente unidose SICCAFLUID, 2,5 mg/g, gel oftálmico em recipiente unidose SICCAFLUID, 2,5 mg/g, gel oftálmico em recipiente unidose Siccafluid, ooggel 2,5 mg/g Siccafree 2,5 mg/g, ooggel in

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FR/H/0118/002

033816051

LABORATOIRES THEA

IT

FR/H/0118/001

341752-2

LABORATOIRES THEA

FR

FR/H/0118/002

360 845-2

LABORATOIRES THEA

FR

FR/H/0118/002

360 847-5

LABORATOIRES THEA

FR

FR/H/0118/002

360 846-9

LABORATOIRES THEA

FR

FR/H/0118/002

360 848-1

LABORATOIRES THEA

FR

FR/H/0118/002

66.890

LABORATORIOS THEA S.A.

ES

FR/H/0118/002

RVG 32027

LABORATOIRES THEA

NL

FR/H/0118/002

5418587

LABORATOIRES THEA

PT

FR/H/0118/002

5418686

LABORATOIRES THEA

PT

FR/H/0118/002

5418785

LABORATOIRES THEA

PT

FR/H/0118/002 FR/H/0118/001 not available

5418884 RVG 29145 RVG 109107

LABORATOIRES THEA LABORATOIRES THEA LABORATOIRES THEA

PT NL NL

List of nationally authorised medicinal products EMA/642432/2017

Page 5/7

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

not available

RVG 109106

LABORATOIRES THEA

NL

not available

36060.00.00

URSAPHARM ARZNEIMITTEL GMBH

DE

not available

43176/10/12-05-2011

ALCON LABORATORIES HELLAS S.A.

GR

not available

9011.00.00

ALCON PHARMA GMBH

DE

not available not available

26211.00.00 PA 555/6/1

DE IE

Vidisic 2 mg/g augnhlaup

not available

910075

Vidisic 2 mg/g gel oftalmic

not available

6192/2006/01

VIDISIC 2 mg/g Ocní gel VIDISIC 2 mg/g ooggel Vidisic 2mg/g gel ophtalmique Vidisic Carbogel 2 mg/ g ooggel Vidisic Carbogel E.D.O. 2 mg/g ooggel VIDISIC EDO 2 mg/g ooggel Vidisic EDO 2mg/g gel ophtalmique Vidisic Gel, 2 mg/ml, gel oftálmico Vidisic Preservative Free Single Dose Unit

not available not available not available not available

64/366/00-C BE145196 BE145196 RVG 14862

ALCON PHARMA GMBH BAUSCH & LOMB UK LTD. DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH BAUSCH & LOMB PHARMA BAUSCH & LOMB PHARMA BAUSCH & LOMB PHARMA

not available not available

RVG 29773 BE230045

BAUSCH & LOMB PHARMA BAUSCH & LOMB PHARMA

NL BE

not available

BE 230045

BAUSCH & LOMB PHARMA

BE

not available

8720904

BAUSCH & LOMB, S.A.

PT

not available

PA 555/6/2

IE

Vidisic szemgél Vidisic® 1 g Augengel enthält 2 mg Carbomer

not available

OGYI-T-4655/01

not available

40612.00.00

Vidisic® EDO® Vidisic® EDO®

not available not available

2000040030 1997095601

BAUSCH & LOMB UK LTD. DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.-

verpakking voor éénmalig gebruik Siccamed 2,5 mg/g, ooggel Siccapos Gel, 2,0 mg/g, Augengel THILOGEL® Οφθαλμική Γέλη 0,3% Thilo-Tears® Gel 3 mg/g Augengel Thilo-Tears® SE 3 mg/g Augengel Vidisic 0.2 % w/w Eye Gel

List of nationally authorised medicinal products EMA/642432/2017

IS RO CZ BE BE NL

HU DE LU LU Page 6/7

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

not available

30620.00.00

not available not available not available

64/0156/93-S 40611.00.00 40614.00.00

not available

57885.00.00

Viscotears 2 mg/g Gel oftálmico Viscotears 2 mg/g ögongel Viscotears 2 mg/g ögongel, endosbehållare Viscotears 2 mg/g øyegel Viscotears 2 mg/g øyegel

not available not available

60.886 12508

not available not available not available

15934 7939 99-6836

Viscotears 2 mg/g silmägeeli

not available

10692

Viscotears Liquid Gel Viscotears silmägeeli kertaannospakkauksessa Viscotears Single Dose Unit 2.0mg/g Eye Gel

not available

PL13757/0020

not available

15608

not available

PL13757/0019

Viscotears, øjengel Viscotears, øjengel i enkeltdosisbeholdere VISCOTER 0,2% οφθαλμική γέλη

not available

15552

not available

32063

not available

24481/10-04-2012

Видизик 2 mg / g гел за очи ОФТАГЕЛ 2,5 mg/g гел за очи

not available not available

20060553 20060214

Vidisic® EDO® 1 g Augengel enthält 2 mg Carbomer VIDISIC® očný gél (carbomerum) Visc-Ophtal® Visc-Ophtal® sine Visc-Ophtal® sine 1 g Augengel enthält 2 mg Carbomer

List of nationally authorised medicinal products EMA/642432/2017

MAH of product in the member state

PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. WINZER PHARMA GMBH DR. WINZER PHARMA GMBH

Member State where product is authorised

DE SK DE DE

DR. WINZER PHARMA GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH LABORATOIRES THEA

DE

LABORATOIRES THEA LABORATOIRES THEA LABORATOIRES THEA DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH

SE NO NO

LABORATOIRES THEA DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH SANTEN OY

GR

ES SE

FI UK FI UK DK DK

BG BG

Page 7/7

PSUSA/00000557/201701 - European Medicines Agency - Europa EU

28 Sep 2017 - Active substance(s): carbomers. Procedure No.: PSUSA/00000557/201701 .... 360 845-2. LABORATOIRES THEA. FR. SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose. FR/H/0118/002. 360 847-5. LABORATOIRES THEA. FR. SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose.

206KB Sizes 46 Downloads 208 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...